Buy IGF-DES (IGF-1 DES 1-3) Online

IGF-DES (IGF-1 DES 1-3) is a synthetic variant of Insulin-Like Growth Factor 1 (IGF-1), a hormone similar in structure to insulin that plays a key role in growth and development. IGF-DES is a modified version of IGF-1, with the removal of the first three amino acids in the peptide chain, making it significantly more potent and effective in certain biological contexts.

Key Characteristics:

• Molecular Formula: C319H501N91O96S7

• Length: 67 amino acids (compared to 70 in regular IGF-1)

• Half-life: Shorter than IGF-1 LR3 (~20-30 minutes), but highly potent locally

• Potency: Up to 10 times more anabolic activity than standard IGF-1 in certain tissues

Benefits and Applications:

1. Muscle Growth and Repair:
   IGF-DES enhances muscle hyperplasia (increase in number of muscle cells) and hypertrophy (growth of muscle cells), especially at the site of injection. This makes it a favorite among bodybuilders and athletes for localized muscle development.

2. Tissue Regeneration:
   Promotes cell division, regeneration, and repair of damaged tissues, making it valuable in injury recovery and anti-aging protocols.

3. Increased Nutrient Delivery:
   Improves uptake of nutrients into muscle cells, facilitating better recovery and enhanced growth during training phases.

4. Reduced Receptor Desensitization:
   Unlike IGF-1 LR3, IGF-DES does not desensitize IGF-1 receptors with prolonged use, allowing for more sustained and targeted effects.

How IGF-DES Works:

IGF-DES binds to IGF-1 receptors and also interacts with insulin receptors, activating pathways such as PI3K/Akt and MAPK, which drive cell growth, proliferation, and survival. It has a unique affinity for damaged or stretched muscle tissue, making it effective when injected directly into targeted areas.

Usage Protocol (for research purposes):

• Dosage: Common research doses range from 20–100 mcg per day, often split into multiple injections.

• Administration: Typically injected intramuscularly near the site of desired growth or injury.

• Cycle Duration: 4–6 weeks, depending on experimental goals.

Potential Side Effects:

• Hypoglycemia (low blood sugar)

• Joint pain

• Water retention

• Organ growth (with excessive use)

• Injection site irritation